While reporting financial results for the first quarter on Thursday, medical devices company AngioDynamics, Inc. (ANGO) maintained its adjusted earnings guidance for the full year 2022, while raising annual net sales outlook.
from RTT - Earnings https://ift.tt/39NUc7f
via IFTTT
No comments:
Post a Comment